Objective
Previous studies showed that both inflammation and platelets have had a role in slow coronary flow (SCF) development. Platelet-to-lymphocyte ratio (PLR) as an emerging inflammatory indicator was significantly associated with cardiovascular adverse events. Therefore, we aimed to assess the relationship between PLR and SCF.
Methods
A total of 514 patients who had angiographically normal coronary arteries were enrolled in this retrospective study (n=221 with SCF group and n=293 with control group). Patients who had thrombolysis in myocardial infarction frame counts (TFC) above the normal cut-offs were considered to have SCF.
Methods
A total of 514 patients who had angiographically normal coronary arteries were enrolled in this retrospective study (n=221 with SCF group and n=293 with control group). Patients who had thrombolysis in myocardial infarction frame counts (TFC) above the normal cut-offs were considered to have SCF.